$BGFV
BIG 5 SPORTING GOODS Corp

2021 Q3 Form 10-Q Financial Statement

#000156459021040716 Filed on August 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q2 2020 Q1
Revenue $326.0M $227.9M $217.7M
YoY Change 6.91% -5.41% -11.23%
Cost Of Revenue $199.1M $155.7M $153.2M
YoY Change 2.14% -7.24% -9.58%
Gross Profit $126.9M $72.20M $64.56M
YoY Change 15.35% -1.25% -14.92%
Gross Profit Margin 38.93% 31.68% 29.65%
Selling, General & Admin $78.38M $58.30M $71.37M
YoY Change 9.87% -19.23% -1.71%
% of Gross Profit 61.75% 80.75% 110.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.414M $4.600M $4.700M
YoY Change -4.04% -6.12% -6.0%
% of Gross Profit 3.48% 6.37% 7.28%
Operating Expenses $78.38M $58.40M $71.37M
YoY Change 9.87% -19.09% -1.71%
Operating Profit $48.54M $16.36M -$6.815M
YoY Change 25.44% 1644.14% -308.73%
Interest Expense $184.0K $749.0K $735.0K
YoY Change -7.54% 1.49% -5.28%
% of Operating Profit 0.38% 4.58%
Other Income/Expense, Net
YoY Change
Pretax Income $48.36M $15.61M -$7.550M
YoY Change 25.61% 7705.5% -403.33%
Income Tax $11.56M $4.475M -$2.939M
% Of Pretax Income 23.9% 28.67%
Net Earnings $36.80M $11.14M -$4.611M
YoY Change 29.62% 39671.43% -377.1%
Net Earnings / Revenue 11.29% 4.89% -2.12%
Basic Earnings Per Share $1.69 $0.52 -$0.22
Diluted Earnings Per Share $1.63 $0.52 -$0.22
COMMON SHARES
Basic Shares Outstanding 21.75M 21.25M 21.15M
Diluted Shares Outstanding 22.59M 21.36M 21.15M

Balance Sheet

Concept 2021 Q3 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $118.9M $16.70M $44.20M
YoY Change 113.54% 153.03% 733.96%
Cash & Equivalents $118.9M $16.74M $44.20M
Short-Term Investments
Other Short-Term Assets $12.00M $8.500M $8.100M
YoY Change 30.4% -12.37% 12.5%
Inventory $258.9M $270.9M $312.3M
Prepaid Expenses $8.129M
Receivables $15.65M $14.90M $7.800M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $405.5M $311.1M $372.5M
YoY Change 22.73% -10.78% 16.63%
LONG-TERM ASSETS
Property, Plant & Equipment $336.9M $333.5M $66.35M
YoY Change -3.85% 365.67% -79.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.40M $12.80M $3.273M
YoY Change -7.61% 271.45% -76.62%
Total Long-Term Assets $353.9M $349.4M $352.6M
YoY Change -3.83% -0.51% 2.02%
TOTAL ASSETS
Total Short-Term Assets $405.5M $311.1M $372.5M
Total Long-Term Assets $353.9M $349.4M $352.6M
Total Assets $759.4M $660.5M $725.1M
YoY Change 8.74% -5.62% 9.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $105.5M $74.20M $73.24M
YoY Change 21.23% -35.46% -29.1%
Accrued Expenses $86.49M $133.0M $53.11M
YoY Change -37.87% 129.1% -55.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.847M $2.600M $2.500M
YoY Change 18.63% 18.18% 13.64%
Total Short-Term Liabilities $269.2M $209.8M $200.8M
YoY Change 12.68% -11.3% -10.54%
LONG-TERM LIABILITIES
Long-Term Debt $4.836M $38.40M $128.3M
YoY Change 61.2% -42.51% 154.56%
Other Long-Term Liabilities $222.4M $225.6M $7.610M
YoY Change 1677.69% 2558.81% -96.46%
Total Long-Term Liabilities $227.3M $264.0M $7.610M
YoY Change 1716.34% 3011.37% -97.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $269.2M $209.8M $200.8M
Total Long-Term Liabilities $227.3M $264.0M $7.610M
Total Liabilities $496.5M $473.9M $550.0M
YoY Change 2.34% -9.73% 12.35%
SHAREHOLDERS EQUITY
Retained Earnings $96.90M
YoY Change
Common Stock $120.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $42.53M
YoY Change
Treasury Stock Shares $3.650M
Shareholders Equity $263.0M $186.6M $175.1M
YoY Change
Total Liabilities & Shareholders Equity $759.4M $660.5M $725.1M
YoY Change 8.74% -5.62% 9.04%

Cashflow Statement

Concept 2021 Q3 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $36.80M $11.14M -$4.611M
YoY Change 29.62% 39671.43% -377.1%
Depreciation, Depletion And Amortization $4.414M $4.600M $4.700M
YoY Change -4.04% -6.12% -6.0%
Cash From Operating Activities $46.74M $63.50M -$5.302M
YoY Change -40.23% -1020.29% -142.28%
INVESTING ACTIVITIES
Capital Expenditures -$2.405M -$1.100M $2.342M
YoY Change 50.31% -56.0% 53.88%
Acquisitions
YoY Change
Other Investing Activities $49.00K $200.0K
YoY Change
Cash From Investing Activities -$2.356M -$900.0K -$2.342M
YoY Change 47.25% -64.0% 53.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -25.60M -90.10M 43.62M
YoY Change -31.93% -942.06% -449.44%
NET CHANGE
Cash From Operating Activities 46.74M 63.50M -5.302M
Cash From Investing Activities -2.356M -900.0K -2.342M
Cash From Financing Activities -25.60M -90.10M 43.62M
Net Change In Cash 18.79M -27.50M 35.98M
YoY Change -51.83% -2215.38% -2554.3%
FREE CASH FLOW
Cash From Operating Activities $46.74M $63.50M -$5.302M
Capital Expenditures -$2.405M -$1.100M $2.342M
Free Cash Flow $49.14M $64.60M -$7.644M
YoY Change -38.42% -1568.18% -169.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
bgfv Financial Information Reporting Period Minimum
FinancialInformationReportingPeriodMinimum
P364D
bgfv Financial Information Reporting Period Maximum
FinancialInformationReportingPeriodMaximum
P371D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y1M2D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y9M14D
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2500000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7725000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
32343000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
31449000
us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
1083000
us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
460000
bgfv Gain On Property Insurance Recoveries Associated With Property Plant And Equipment
GainOnPropertyInsuranceRecoveriesAssociatedWithPropertyPlantAndEquipment
249000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
36803000
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
26355000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
824000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
262951000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
175058000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
11136000
CY2020Q2 bgfv Common Stock Forfeitures Dividends Payable
CommonStockForfeituresDividendsPayable
4000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
406000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
186604000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
232638000
us-gaap Net Income Loss
NetIncomeLoss
58349000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
29694000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1800000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
904000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1046000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
262951000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
180372000
us-gaap Net Income Loss
NetIncomeLoss
6525000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1077000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
881000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
97000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
186604000
us-gaap Profit Loss
ProfitLoss
58349000
us-gaap Profit Loss
ProfitLoss
6525000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8648000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9137000
us-gaap Share Based Compensation
ShareBasedCompensation
904000
us-gaap Share Based Compensation
ShareBasedCompensation
881000
bgfv Amortization Of Other Assets
AmortizationOfOtherAssets
366000
bgfv Amortization Of Other Assets
AmortizationOfOtherAssets
172000
us-gaap Gain Loss On Condemnation
GainLossOnCondemnation
2500000
us-gaap Proceeds From Other Operating Activities
ProceedsFromOtherOperatingActivities
2263000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
435000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
837000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-3608000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1254000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-38391000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
675000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2158000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
24478000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2612000
bgfv Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-33704000
bgfv Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-32408000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1337000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-33000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
88738000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
58230000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4105000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3444000
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
249000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-237000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3856000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3207000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
137296000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
168855000
us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
56000
us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
-12136000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
717000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
105000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1559000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1409000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1800000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1046000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
97000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
29130000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1205000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30596000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-46511000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
54286000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8512000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64654000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8223000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118940000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16735000
bgfv Finance Lease Obligations Incurred
FinanceLeaseObligationsIncurred
4649000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1437000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
496000
us-gaap Interest Paid Net
InterestPaidNet
356000
us-gaap Interest Paid Net
InterestPaidNet
1570000
us-gaap Income Taxes Paid
IncomeTaxesPaid
10889000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Management makes a number of estimates and assumptions relating to the reporting of assets, liabilities and stockholders’ equity and the disclosure of contingent assets and liabilities at the date of the Interim Financial Statements and reported amounts of revenue and expense during the reporting period to prepare these Interim Financial Statements in conformity with GAAP. Certain items subject to such estimates and assumptions include the carrying amount of merchandise inventories, property and equipment, lease assets and lease liabilities; valuation allowances for receivables, sales returns and deferred income tax assets; estimates related to stored-value cards and the valuation of share-based compensation awards; and obligations related to litigation, self-insurance liabilities and employee benefits. Due to the inherent uncertainty involved in making assumptions and estimates, events and changes in circumstances arising after July 4, 2021, including those resulting from the impacts of the COVID-19 pandemic, may result in actual outcomes that differ from those contemplated by management’s assumptions and estimates.</p>
CY2021Q3 us-gaap Number Of Stores
NumberOfStores
430
CY2021Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
11000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Fiscal Period
FiscalPeriod
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Reporting Period</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company follows the concept of a 52-53 week fiscal year, which ends on the Sunday nearest December 31. Fiscal year 2021 is comprised of 52 weeks and ends on January 2, 2022. Fiscal year 2020 was comprised of 53 weeks and ended on January 3, 2021. The four quarters of fiscal 2021 are each comprised of <span style="-sec-ix-hidden:F_000356"><span style="-sec-ix-hidden:F_000358"><span style="-sec-ix-hidden:F_000360"><span style="-sec-ix-hidden:F_000362">13 weeks</span></span></span></span>. The first three quarters in fiscal 2020 were each comprised of <span style="-sec-ix-hidden:F_000357"><span style="-sec-ix-hidden:F_000359"><span style="-sec-ix-hidden:F_000361">13 weeks</span></span></span>, and the fourth quarter of fiscal 2020 was comprised of <span style="-sec-ix-hidden:F_000363">14 weeks</span>.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br/></p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">COVID-19 Impact on Concentration of Risk</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The novel coronavirus (“COVID-19”) pandemic has significantly impacted health and economic conditions throughout the United States and globally, as public concern about becoming ill with the virus has led to the issuance of recommendations and/or mandates from federal, state and local authorities to practice social distancing or self-quarantine. </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company primarily operates traditional sporting goods retail stores located in the western United States, with approximately 52% of its stores, along with its corporate offices and distribution center, located in California. Because of this, the Company is subject to regional risks, including the impact of the COVID-19 outbreak. Beginning on March 20, 2020, and continuing into the second quarter of fiscal 2020, the Company temporarily closed more than <span style="-sec-ix-hidden:F_000364_2">one-half</span> of its retail store locations in response to state and local shelter orders related to the COVID-19 outbreak. The Company was subsequently able to gradually reopen its store locations based on initially qualifying as an “essential” business under applicable regulations and later as a result of the easing of regulatory restrictions on retail operations in the Company’s market areas. In an effort to promote social distancing protocols, the Company implemented reduced store hours, limited the number of customers in its stores at any one time and generally implemented social-distancing guidelines throughout the store operating space in fiscal 2020. As of the end of fiscal 2020 and during the first half of fiscal 2021, all of the Company’s stores were open for in-store shopping with reduced operating hours and certain COVID-19-related protocols in place. The Company may further restrict its store operations and operations in its distribution facility if deemed necessary or if recommended or mandated by authorities, and new temporary closures of stores or new safety protocols may be required if additional orders are issued in response to changing health conditions.</p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">General Concentration of Risk</p> <p style="text-align:justify;Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company purchases merchandise from over 680 suppliers, and the Company’s 20 largest suppliers accounted for 36.4% of total purchases in fiscal 2020. One vendor, Nike, represented greater than 5% of total purchases, at 8.5%, in fiscal 2020 and accounted for 7.2% of the Company’s total sales in fiscal 2020. In the first quarter of fiscal 2021, <span style="color:#000000;">the Company was informed of an expansion of Nike’s</span> direct-to-consumer initiatives that will impact certain multi-branded retailers, including the Company, and which will lead to a significant reduction in the Company’s future supply chain relative to this vendor. This transition is not expected to impact the Company’s ability to continue to purchase certain Nike branded products from authorized licensees. <span style="color:#000000;">The Company</span> is actively expanding its relationships with other new and existing vendors in order to replace the affected Nike product within its product mix. </p>
CY2021 bgfv Concentration Risk Number Of Suppliers
ConcentrationRiskNumberOfSuppliers
680
CY2021 bgfv Concentration Of Risk Number Of Major Customers
ConcentrationOfRiskNumberOfMajorCustomers
20
CY2021Q1 bgfv Concentration Risk Percentage Of Purchases
ConcentrationRiskPercentageOfPurchases
0.364
CY2021Q1 bgfv Concentration Risk Number Of Customers That Accounted For Greater Than Five Percent Of Purchases
ConcentrationRiskNumberOfCustomersThatAccountedForGreaterThanFivePercentOfPurchases
1
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
326020000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
227935000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
598826000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
445671000
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
one
CY2021Q3 bgfv Stored Value Card Redemption Revenue Recognized
StoredValueCardRedemptionRevenueRecognized
1500000
bgfv Stored Value Card Redemption Revenue Recognized
StoredValueCardRedemptionRevenueRecognized
3200000
CY2020Q2 bgfv Stored Value Card Redemption Revenue Recognized
StoredValueCardRedemptionRevenueRecognized
800000
bgfv Stored Value Card Redemption Revenue Recognized
StoredValueCardRedemptionRevenueRecognized
2600000
CY2021Q3 bgfv Stored Value Card Liabilities
StoredValueCardLiabilities
7000000.0
CY2021Q1 bgfv Stored Value Card Liabilities
StoredValueCardLiabilities
7500000
bgfv Revenue Recognition Gift Cards Redemption Period
RevenueRecognitionGiftCardsRedemptionPeriod
P2Y
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86486000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
82877000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
720000
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
689000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
121000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
167000
CY2021Q3 bgfv Finance Lease Expense
FinanceLeaseExpense
782000
CY2020Q2 bgfv Finance Lease Expense
FinanceLeaseExpense
767000
bgfv Finance Lease Expense
FinanceLeaseExpense
1490000
bgfv Finance Lease Expense
FinanceLeaseExpense
1578000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
20384000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
20318000
us-gaap Operating Lease Cost
OperatingLeaseCost
40720000
us-gaap Operating Lease Cost
OperatingLeaseCost
40604000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
4711000
us-gaap Variable Lease Cost
VariableLeaseCost
9203000
us-gaap Variable Lease Cost
VariableLeaseCost
5981000
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
293000
us-gaap Sublease Income
SubleaseIncome
78000
us-gaap Sublease Income
SubleaseIncome
586000
CY2021Q3 us-gaap Lease Cost
LeaseCost
25877000
CY2020Q2 us-gaap Lease Cost
LeaseCost
22257000
us-gaap Lease Cost
LeaseCost
51335000
us-gaap Lease Cost
LeaseCost
47577000
us-gaap Operating Lease Payments
OperatingLeasePayments
43168000
us-gaap Operating Lease Payments
OperatingLeasePayments
37354000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1559000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1409000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
134000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
167000
bgfv Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
44861000
bgfv Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
38930000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
4652000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
32529000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
39986000
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2020Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y9M18D
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.034
CY2020Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.047
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.056
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.064
CY2021Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
1952000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
43414000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
2640000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
81263000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1772000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
64547000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
900000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
55741000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
434000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
39378000
CY2021Q3 bgfv Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
388000
CY2021Q3 bgfv Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
47108000
CY2021Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
8086000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
331451000
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y9M18D
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.034
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.056
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
7683000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
290338000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2847000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
74382000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4836000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
215956000
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
7683000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
290338000
CY2021Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
403000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
41113000
us-gaap Line Of Credit Facility Description
LineOfCreditFacilityDescription
The Company, Big 5 Corp. and Big 5 Services Corp. were parties to a credit agreement with Wells Fargo Bank, National Association (“Wells Fargo”), as administrative agent, and a syndicate of other lenders, as amended (the “Prior Credit Agreement”), which was terminated and replaced on February 24, 2021, as discussed below.
CY2021Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
700000
CY2021Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0
CY2021Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0
CY2021Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2600000
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
300000
bgfv Cares Act Of2020 Net Operating Loss Carryback Description
CARESActOf2020NetOperatingLossCarrybackDescription
the CARES Act allows companies with a net operating loss (“NOL”) in either 2018, 2019 or 2020 to carry back those losses five years.
bgfv Cares Act Of2020 Net Operating Loss Carryback Period
CARESActOf2020NetOperatingLossCarrybackPeriod
P5Y
CY2020Q2 us-gaap Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority
IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
2100000
CY2021Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2021Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
bgfv Unrecognized Tax Benefits Period That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsPeriodThatWouldImpactEffectiveTaxRate
over the next 12 months
CY2021Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
36803000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
11136000
us-gaap Net Income Loss
NetIncomeLoss
58349000
us-gaap Net Income Loss
NetIncomeLoss
6525000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21746000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21252000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21582000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21200000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
847000
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
106000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
925000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
156000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22593000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21358000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22507000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21356000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.69
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.70
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.63
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2020Q2 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
2500000
CY2020Q2 bgfv Number Of Stores Destroyed In Civil Unrest
NumberOfStoresDestroyedInCivilUnrest
7
CY2020Q2 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
600000
CY2021Q2 bgfv Loss Contingency Receivable Deduction
LossContingencyReceivableDeduction
300000
CY2021Q2 bgfv Proceeds From Insurance Recoveries Net
ProceedsFromInsuranceRecoveriesNet
1300000
CY2021Q2 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
200000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000
CY2021Q2 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
500000
CY2021Q2 bgfv Gain On Property Insurance Recoveries Associated With Property Plant And Equipment
GainOnPropertyInsuranceRecoveriesAssociatedWithPropertyPlantAndEquipment
200000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.630
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
70228
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1000000.0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
742800
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.62
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
317675
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.67
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
425125
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.84
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
9361153
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
51882
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.19
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
968908
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
418485
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.86
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
9207362
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M12D

Files In Submission

Name View Source Status
0001564590-21-040716-index-headers.html Edgar Link pending
0001564590-21-040716-index.html Edgar Link pending
0001564590-21-040716.txt Edgar Link pending
0001564590-21-040716-xbrl.zip Edgar Link pending
bgfv-10q_20210704.htm Edgar Link pending
bgfv-10q_20210704_htm.xml Edgar Link completed
bgfv-20210704.xsd Edgar Link pending
bgfv-20210704_cal.xml Edgar Link unprocessable
bgfv-20210704_def.xml Edgar Link unprocessable
bgfv-20210704_lab.xml Edgar Link unprocessable
bgfv-20210704_pre.xml Edgar Link unprocessable
bgfv-ex151_593.htm Edgar Link pending
bgfv-ex311_258.htm Edgar Link pending
bgfv-ex312_513.htm Edgar Link pending
bgfv-ex321_260.htm Edgar Link pending
bgfv-ex322_423.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending